市场调查报告书
商品编码
1182182
猴痘检测全球市场规模研究与预测,按技术(聚合□链反应(PCR)、侧流分析(LFA)等),用户(医院/诊所、诊断实验室等)区域分析2022-2029Global Monkeypox Testing Market Size study & Forecast, by Technology (Polymerase Chain Reaction (PCR), Lateral Flow Assay (LFA), Others), by End-User (Hospitals and Clinics, Diagnostic Laboratories, Others) and Regional Analysis, 2022-2029 |
2021 年全球猴痘检测市场价值约为 179 万美元,预计在 2022-2029 年预测期内将以超过 4.35% 的健康增长率增长。
猴痘是一种病毒性人畜共患疾病,其症状与天花相似,通常包括皮疹、淋巴结肿大、发烧和各种并发症。 猴痘通过与受感染的个人或动物密切接触,或通过接触被病毒污染的材料传播给人类。 猴痘检测是一种用于诊断疾病、检测病情、规划治疗、治疗能力或随时间监测病情的程序。 公众意识的提高以及政府支持和举措的增加正在推动全球市场的增长。
世界范围内猴痘负担的增加增加了检测的必要性,以便及时获得治疗并避免潜在的严重情况。 根据美国疾病控制与预防中心的数据,截至 2022 年 9 月 27 日,全球已报告 66,551 例病例,其中 26 人死亡。 与其他地区相比,美国和欧洲的註册患者人数估计最多。 因此,目标疾病的流行率不断上升,对猴痘检测产生了巨大的利润丰厚的需求。 此外,由于诊断研究的进步和研发活动资金的增加,预测期内各种增长前景都很突出。 然而,根除疫情的困难和与研发活动相关的高成本阻碍了整个 2022-2029 年预测期内的市场增长。
全球猴痘检测市场研究中考虑的主要区域是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。 由于猴痘发病率上升和各种成熟市场参与者的存在,北美在收入方面占据了市场主导地位。 另一方面,预计欧洲在预测期内将呈现显着的增长率。 政府支持的增加、病毒的高发病率和流行率以及对扩大该地区检测能力的日益关注等因素推动了预测期内的市场增长。
本研究的目的是阐明近年来各个细分市场和国家/地区的市场规模,并预测未来几年的市场规模。 该报告旨在包括被调查国家工业的定性和定量方面。
它还提供了关键方面的详细信息,例如决定市场未来增长的驱动因素和挑战。 此外,它还包含供利益相关者投资的微观市场潜在机会,以及对主要参与者的竞争格局和产品供应的深入分析。
Global Monkeypox Testing Market is valued at approximately USD 1.79 million in 2021 and is anticipated to grow with a healthy growth rate of more than 4.35% over the forecast period 2022-2029. Monkeypox is a viral zoonotic disease that is similar symptoms to smallpox, which generally includes rash and swollen lymph nodes, fever, and a variety of medical complications. Monkeypox is spread in humans through close contact with a diseased individual or animal, or with material that is contaminated with the virus. Monkeypox testing is a procedure for the diagnosis of disease and detecting a condition, planning treatment, treatment competence, or monitoring the condition over time. The growing awareness among the population and increasing government support and initiatives are driving market growth across the globe.
The rising burden of monkeypox around the world is propelling the need for testing to receive treatment on time and evade the chances of a serious condition. According to the Centers for Disease Control and Prevention, on 27th September 2022, 66,551 cases were reported with 26 deaths around the world. The United States and Europe are estimated to have the highest number of registered cases compared to other regions. Thereby, the rising prevalence of the target disease is creating a lucrative demand for monkeypox testing at a substantial rate. Moreover, the rising advancements in diagnosis research, as well as growing funding for research and development activities are offering various growth prospects in the forecasting years. However, difficulty in determining the cause of the spread and high costs related to the R&D activities are hindering market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Monkeypox Testing Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America dominated the market in terms of revenue, owing to the rising incidence of monkeypox and the presence of various well-established market players. Whereas, Europe is expected to grow at a significant growth rate during the forecast period. Factors such as rising government support, the highest occurrence and spread of the virus, as well as growing focus on expanding testing capacities in the region are burgeoning the market growth in the forecasting years.
Major market players included in this report are:
Aegis Sciences Corporation
Laboratory Corp. of America Holdings
Quest Diagnostics, Inc.
Sonic Healthcare Ltd.
QIAGEN
Mayo Clinic Laboratories
Chembio Diagnostics, Inc.
Sonora Quest Laboratories
Thermo Fisher Scientific
Becton, Dickinson, and Company
Recent Developments in the Market:
Global Monkeypox Testing Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Technology, End-User, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.
The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Technology:
Polymerase Chain Reaction (PCR)
Lateral Flow Assay (LFA)
Others
By End-User:
Hospitals and Clinics
Diagnostic Laboratories
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
ROLA
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable